Inferred Allelic Variants of Immunoglobulin Receptor Genes: A System for Their Evaluation, Documentation, and Naming.

Autor: Ohlin M; Department of Immunotechnology, Lund University, Lund, Sweden., Scheepers C; Center for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa.; Faculty of Health Sciences, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa., Corcoran M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden., Lees WD; Institute of Structural and Molecular Biology, Birkbeck College, University of London, London, United Kingdom., Busse CE; Division of B Cell Immunology, German Cancer Research Center, Heidelberg, Germany., Bagnara D; Department of Experimental Medicine, University of Genoa, Genoa, Italy., Thörnqvist L; Department of Immunotechnology, Lund University, Lund, Sweden., Bürckert JP; BISC Global Inc., Boston, MA, United States., Jackson KJL; Immunology Division, The Garvan Institute of Medical Research, Darlinghurst, NSW, Australia., Ralph D; Fred Hutchinson Cancer Research Center, Seattle, WA, United States., Schramm CA; Vaccine Research Center, National Institutes of Health, Washington, DC, United States., Marthandan N; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada., Breden F; Department of Biological Sciences, Simon Fraser University, Burnaby, BC, Canada., Scott J; Department of Molecular Biology and Biochemistry, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada., Matsen Iv FA; Fred Hutchinson Cancer Research Center, Seattle, WA, United States., Greiff V; Department of Immunology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Yaari G; Faculty of Engineering, Bar Ilan University, Ramat Gan, Israel., Kleinstein SH; Department of Pathology, Yale University, New Haven, CT, United States., Christley S; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States., Sherkow JS; Innovation Center for Law and Technology, New York Law School, New York, NY, United States., Kossida S; IMGT®, The International ImMunoGenetics information system® (IMGT), Laboratoire d'ImmunoGénétique Moléculaire (LIGM), CNRS, Institut de Génétique Humaine, Université de Montpellier, Montpellier, France., Lefranc MP; IMGT®, The International ImMunoGenetics information system® (IMGT), Laboratoire d'ImmunoGénétique Moléculaire (LIGM), CNRS, Institut de Génétique Humaine, Université de Montpellier, Montpellier, France., van Zelm MC; Department of Immunology and Pathology, Central Clinical School, The Alfred Hospital, Monash University, Melbourne, VIC, Australia., Watson CT; Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY, United States., Collins AM; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.

Publikováno v: Frontiers in immunology [Front Immunol] 2019 Mar 18; Vol. 10, pp. 435. Date of Electronic Publication: 2019 Mar 18 (Print Publication: 2019).

Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling.

Autor: Hahn M; Institute for Molecular Medicine, University Medical Centre of the Johannes Gutenberg-University of Mainz, Mainz, Germany., Bürckert JP; Department of Infection and Immunity, Luxembourg Institute of Health, Strassen, Luxembourg., Luttenberger CA; Institute for Molecular Medicine, University Medical Centre of the Johannes Gutenberg-University of Mainz, Mainz, Germany., Klebow S; Institute for Molecular Medicine, University Medical Centre of the Johannes Gutenberg-University of Mainz, Mainz, Germany., Hess M; Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Centre of the Johannes Gutenberg-University of Mainz, Mainz, Germany., Al-Maarri M; Max Planck Institute for Metabolism Research, CECAD, CMMC, Institute for Genetics, Cologne, Germany., Vogt M; Max Planck Institute for Metabolism Research, CECAD, CMMC, Institute for Genetics, Cologne, Germany., Reißig S; Institute for Molecular Medicine, University Medical Centre of the Johannes Gutenberg-University of Mainz, Mainz, Germany., Hallek M; Department I of Internal Medicine, CMMC, CECAD, University of Cologne, Cologne, Germany., Wienecke-Baldacchino A; Life Science Research Unit (LSRU), University of Luxembourg, Esch-sur-Alzette, Luxembourg., Buch T; Institute of Laboratory Animal Science, University of Zürich, Zürich, Switzerland., Muller CP; Department of Infection and Immunity, Luxembourg Institute of Health, Strassen, Luxembourg., Pallasch CP; Department I of Internal Medicine, CMMC, CECAD, University of Cologne, Cologne, Germany., Wunderlich FT; Max Planck Institute for Metabolism Research, CECAD, CMMC, Institute for Genetics, Cologne, Germany., Waisman A; Institute for Molecular Medicine, University Medical Centre of the Johannes Gutenberg-University of Mainz, Mainz, Germany., Hövelmeyer N; Institute for Molecular Medicine, University Medical Centre of the Johannes Gutenberg-University of Mainz, Mainz, Germany.

Publikováno v: Leukemia [Leukemia] 2018 Jan; Vol. 32 (1), pp. 72-82. Date of Electronic Publication: 2017 Jun 01.

Adaptive Immune Receptor Repertoire Community recommendations for sharing immune-repertoire sequencing data.

Autor: Rubelt F; Department of Microbiology and Immunology and Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California, USA., Busse CE; Division of B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Bukhari SAC; Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA., Bürckert JP; Department of Infection and Immunity, Luxembourg Institute of Health, Luxembourg, Luxembourg., Mariotti-Ferrandiz E; Sorbonne Universités, UPMC Univ Paris 06, INSERM, UMR_S 959, Immunology-Immunopathology-Immunotherapy (i3), Paris, France., Cowell LG; Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, Texas, USA., Watson CT; Department of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, Kentucky, USA., Marthandan N; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada., Faison WJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA., Hershberg U; School of Biomedical Engineering, Science & Health Systems, and Department of Microbiology and Immunology, College of Medicine, Drexel University, Philadelphia, Pennsylvania, USA., Laserson U; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Corrie BD; iReceptor, Simon Fraser University, Burnaby, British Columbia, Canada.; Department of Biological Sciences, Simon Fraser University, Burnaby, British Columbia, Canada., Davis MM; Department of Microbiology and Immunology and Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California, USA.; Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, California, USA., Peters B; La Jolla Institute for Allergy and Immunology, La Jolla, California, USA., Lefranc MP; IMGT, the international ImMunoGeneTics information system, LIGM, Institut de Génétique Humaine IGH, CNRS, University of Montpellier, Montpellier, France., Scott JK; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada.; iReceptor, Simon Fraser University, Burnaby, British Columbia, Canada.; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada., Breden F; iReceptor, Simon Fraser University, Burnaby, British Columbia, Canada.; Department of Biological Sciences, Simon Fraser University, Burnaby, British Columbia, Canada., Luning Prak ET; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kleinstein SH; Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.; Department of Immunobiology, Yale School of Medicine, and Interdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut, USA.

Publikováno v: Nature immunology [Nat Immunol] 2017 Nov 16; Vol. 18 (12), pp. 1274-1278.

Measles Virus Hemagglutinin Protein Epitopes: The Basis of Antigenic Stability.

Autor: Tahara M; Department of Virology 3, National Institute of Infectious Diseases, Musashimurayama 208-0011, Tokyo, Japan. maino@nih.go.jp., Bürckert JP; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette L-4354, Luxembourg. Jean-Philippe.Buerckert@lih.lu., Kanou K; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Shinjuku-ku 162-8640, Tokyo, Japan. kanou@nih.go.jp., Maenaka K; Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Hokkaido, Japan. maenaka@pharm.hokudai.ac.jp., Muller CP; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette L-4354, Luxembourg. Claude.Muller@lih.lu., Takeda M; Department of Virology 3, National Institute of Infectious Diseases, Musashimurayama 208-0011, Tokyo, Japan. mtakeda@nih.go.jp.

Publikováno v: Viruses [Viruses] 2016 Aug 02; Vol. 8 (8). Date of Electronic Publication: 2016 Aug 02.